ORAMED PHARMACEUTICALS INC. - 31 Dec 2025 SCHEDULE 13G/A Report for Scilex Holding Co Common Stock, par value $0.0001 per share (SCLX)

Filing Manager: ORAMED PHARMACEUTICALS INC.
Reporting Manager: Oramed Pharmaceuticals Inc.
Security: Scilex Holding Co Common Stock, par value $0.0001 per share
Symbol: SCLX
Shares outstanding: 8,928,776 shares
Disclosed Ownership: 437,510 shares
Ownership: 4.9%
Form type: SCHEDULE 13G/A
Filing time: 13 Feb 2026, 16:10:03 UTC
Date of event: 31 Dec 2025
Previous filing: 14 Nov 2025
SEC: View on sec.gov

Reporting Managers (1)

Name	Ownership	Shares Owned	sole voting power	shared voting power	Signature	Title	CIK
Oramed Pharmaceuticals Inc.	4.9%	437,510	437,510	0	/s/ Avraham Gabay	Avraham Gabay, Chief Financial Officer